Attached files
file | filename |
---|---|
EX-99.1 - EX-99.1 - WebMD Health Corp. | d343117dex991.htm |
8-K - FORM 8-K - WebMD Health Corp. | d343117d8k.htm |
EX-99.3 - EX-99.3 - WebMD Health Corp. | d343117dex993.htm |
EX-99.4 - EX-99.4 - WebMD Health Corp. | d343117dex994.htm |
Exhibit 99.2
WEBMD HEALTH CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data, unaudited)
Three Months Ended March 31, |
||||||||
2012 | 2011 | |||||||
Revenue |
$ | 106,947 | $ | 131,609 | ||||
Cost of operations |
53,471 | 48,449 | ||||||
Sales and marketing |
30,103 | 32,294 | ||||||
General and administrative |
29,022 | 22,821 | ||||||
Depreciation and amortization |
6,930 | 6,424 | ||||||
Interest income |
11 | 16 | ||||||
Interest expense |
5,836 | 3,141 | ||||||
Gain on investments |
8,074 | 14,060 | ||||||
Other expense |
1,200 | 53 | ||||||
|
|
|
|
|||||
(Loss) income before income tax (benefit) provision |
(11,530) | 32,503 | ||||||
Income tax (benefit) provision |
(3,753) | 12,958 | ||||||
|
|
|
|
|||||
Net (loss) income |
$ | (7,777) | $ | 19,545 | ||||
|
|
|
|
|||||
Net (loss) income per common share: |
||||||||
Basic |
$ | (0.14) | $ | 0.33 | ||||
|
|
|
|
|||||
Diluted |
$ | (0.14) | $ | 0.32 | ||||
|
|
|
|
|||||
Weighted-average shares outstanding used in computing (loss) income per common share: |
||||||||
Basic |
55,769 | 58,184 | ||||||
|
|
|
|
|||||
Diluted |
55,769 | 67,173 | ||||||
|
|
|
|
WEBMD HEALTH CORP.
CONSOLIDATED SUPPLEMENTAL FINANCIAL INFORMATION
(In thousands, unaudited)
Three Months Ended March 31, |
||||||||
2012 | 2011 | |||||||
Revenue |
||||||||
Public portal advertising and sponsorship |
$ | 87,776 | $ | 110,363 | ||||
Private portal services |
19,171 | 21,246 | ||||||
|
|
|
|
|||||
$ | 106,947 | $ | 131,609 | |||||
|
|
|
|
|||||
Earnings before interest, taxes, non-cash and other items (Adjusted EBITDA) (a) |
$ | 11,251 | $ | 37,858 | ||||
Interest, taxes, non-cash and other items (b) |
||||||||
Interest income |
11 | 16 | ||||||
Interest expense |
(5,836) | (3,141) | ||||||
Income tax benefit (provision) |
3,753 | (12,958) | ||||||
Depreciation and amortization |
(6,930) | (6,424) | ||||||
Non-cash stock-based compensation |
(16,900) | (9,813) | ||||||
Gain on investments |
8,074 | 14,060 | ||||||
Other expense |
(1,200) | (53) | ||||||
|
|
|
|
|||||
Net (loss) income |
$ | (7,777) | $ | 19,545 | ||||
|
|
|
|
(a) | See Annex A-Explanation of Non-GAAP Financial Measures. |
(b) | Reconciliation of Adjusted EBITDA to net (loss) income. |
WEBMD HEALTH CORP.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, unaudited)
March 31, 2012 | December 31, 2011 | |||||||
Assets |
||||||||
Cash and cash equivalents |
$ | 1,142,066 | $ | 1,121,217 | ||||
Accounts receivable, net |
97,445 | 121,335 | ||||||
Prepaid expenses and other current assets |
15,442 | 12,690 | ||||||
Deferred tax assets |
21,316 | 20,482 | ||||||
|
|
|
|
|||||
Total current assets |
1,276,269 | 1,275,724 | ||||||
Property and equipment, net |
53,621 | 57,139 | ||||||
Goodwill |
202,104 | 202,104 | ||||||
Intangible assets, net |
19,343 | 19,999 | ||||||
Deferred tax assets |
51,953 | 55,017 | ||||||
Other assets |
29,957 | 31,042 | ||||||
|
|
|
|
|||||
Total Assets |
$ | 1,633,247 | $ | 1,641,025 | ||||
|
|
|
|
|||||
Liabilities and Stockholders Equity |
||||||||
Accrued expenses |
$ | 44,076 | $ | 55,238 | ||||
Deferred revenue |
90,321 | 88,055 | ||||||
Liabilities of discontinued operations |
1,506 | 1,506 | ||||||
|
|
|
|
|||||
Total current liabilities |
135,903 | 144,799 | ||||||
2.25% convertible notes due 2016 |
400,000 | 400,000 | ||||||
2.50% convertible notes due 2018 |
400,000 | 400,000 | ||||||
Other long-term liabilities |
21,503 | 21,790 | ||||||
Stockholders equity |
675,841 | 674,436 | ||||||
|
|
|
|
|||||
Total Liabilities and Stockholders Equity |
$ | 1,633,247 | $ | 1,641,025 | ||||
|
|
|
|
WEBMD HEALTH CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, unaudited)
Three Months Ended March 31, |
||||||||
2012 | 2011 | |||||||
Cash flows from operating activities: |
||||||||
Net (loss) income |
$ | (7,777) | $ | 19,545 | ||||
Adjustments to reconcile net (loss) income to net cash provided by operating activities: |
||||||||
Depreciation and amortization |
6,930 | 6,424 | ||||||
Non-cash interest, net |
1,082 | 516 | ||||||
Non-cash stock-based compensation |
16,900 | 9,813 | ||||||
Deferred income taxes |
(3,971) | 4,798 | ||||||
Gain on investments |
(8,074) | (14,060) | ||||||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable |
23,890 | 5,688 | ||||||
Prepaid expenses and other, net |
(4,023) | 622 | ||||||
Accrued expenses and other long-term liabilities |
(11,694) | (7,642) | ||||||
Deferred revenue |
2,266 | (219) | ||||||
|
|
|
|
|||||
Net cash provided by continuing operations |
15,529 | 25,485 | ||||||
Net cash used in discontinued operations |
- | (142) | ||||||
|
|
|
|
|||||
Net cash provided by operating activities |
15,529 | 25,343 | ||||||
Cash flows from investing activities: |
||||||||
Proceeds received from ARS option |
9,269 | 5,240 | ||||||
Purchases of property and equipment |
(3,377) | (4,849) | ||||||
|
|
|
|
|||||
Net cash provided by investing activities |
5,892 | 391 | ||||||
Cash flows from financing activities: |
||||||||
Proceeds from exercise of stock options |
754 | 10,220 | ||||||
Cash used for withholding taxes due on stock-based awards |
(911) | (3,172) | ||||||
Net proceeds from issuance of the 2.50% Notes and 2.25% Notes |
- | 774,745 | ||||||
Purchases of treasury stock |
(415) | (150,000) | ||||||
Excess tax benefit on stock-based awards |
- | 7,355 | ||||||
|
|
|
|
|||||
Net cash (used in) provided by financing activities |
(572) | 639,148 | ||||||
|
|
|
|
|||||
Net increase in cash and cash equivalents |
20,849 | 664,882 | ||||||
Cash and cash equivalents at beginning of period |
1,121,217 | 400,501 | ||||||
|
|
|
|
|||||
Cash and cash equivalents at end of period |
$ | 1,142,066 | $ | 1,065,383 | ||||
|
|
|
|